H
Harrow Health D
D
HROW
30.610
USD
-0.92
(-2.92%)
مغلق
حجم التداول
14,676
الربح لكل سهم
-0
العائد الربحي
-
P/E
-51
حجم السوق
1,123,373,317
الأخبار المقالات
العنوان: Harrow
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sightby making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.